Cash Flow Statement

Amortization of Deferred Charges Amortization of Deferred Charges Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Cash Depreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Net Cash Flow Net Cash Flow Net Income Other financing activities Other financing activities Share-based Compensation Share-based Compensation Shares Issued

Daily Values

Others

Ratios

Camp4 Therapeutics (CAMP) Non-cash Items (2023 - 2024)

Camp4 Therapeutics' Non-cash Items history spans 2 years, with the latest figure at $1.0 million for Q3 2024.

On a quarterly basis, Non-cash Items changed N/A to $1.0 million in Q3 2024 year-over-year; TTM through Sep 2024 was $1.0 million, a N/A change, with the full-year FY2023 number at $6.9 million, changed N/A from a year prior.
Non-cash Items hit $1.0 million in Q3 2024 for Camp4 Therapeutics, down from $6.9 million in the prior quarter.
Over the last five years, Non-cash Items for CAMP hit a ceiling of $6.9 million in Q4 2023 and a floor of $1.0 million in Q3 2024.